Cargando…

The Cat and Mouse of HIV-1 Antibody Escape

Detalles Bibliográficos
Autor principal:	Mascola, John R.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2742737/ https://www.ncbi.nlm.nih.gov/pubmed/19763273 http://dx.doi.org/10.1371/journal.ppat.1000592

Ejemplares similares

The paradigm of immune escape by SARS-CoV-2 variants and strategies for repositioning subverted mAbs against escaped VOCs
por: Shah, Masaud, et al.
Publicado: (2022)

Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01
por: Lynch, RM, et al.
Publicado: (2012)

Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape
por: White, Martyn K., et al.
Publicado: (2016)

Molecular basis for KDEL-mediated retrieval of escaped ER-resident proteins – SWEET talking the COPs
por: Newstead, Simon, et al.
Publicado: (2020)

Evaluation of the Application for new alternative biodiesel production process for rendered fat of Cat 1 (BDI‐RepCat process, AT)
por: Ricci, Antonia, et al.
Publicado: (2017)

Few and Far Between: How HIV May Be Evading Antibody Avidity
por: Klein, Joshua S., et al.
Publicado: (2010)

“Rational Vaccine Design” for HIV Should Take into Account the Adaptive Potential of Polyreactive Antibodies
por: Dimitrov, Jordan D., et al.
Publicado: (2011)

How Schrödinger's cat escaped the box
por: Rowlands, Peter
Publicado: (2015)

Xenotransfusion of Blood from Dog to Cat: Should Canine Blood Be Our First Choice for Feline Transfusion in Emergency Situations?
por: Deschamps, Jack-Yves, et al.
Publicado: (2022)

HIV-1 Group M Conserved Elements Vaccine
por: Rolland, Morgane, et al.
Publicado: (2007)

Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies
por: Diskin, Ron, et al.
Publicado: (2013)

Measles Outbreak in Africa—Is There a Link to the HIV-1 Epidemic?
por: Nilsson, Anna, et al.
Publicado: (2011)

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
por: Charpentier, Charlotte, et al.
Publicado: (2023)

HIV, malaria and beyond: reducing the disease burden of female adolescents
por: Brabin, Loretta, et al.
Publicado: (2005)

Safety and efficacy of ponceau 4R for cats, dogs and ornamental fish
por: Rychen, Guido, et al.
Publicado: (2018)

Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody
por: Schommers, Philipp, et al.
Publicado: (2020)

Cat Dilemma: Too Protected To Escape Trophy Hunting?
por: Palazy, Lucille, et al.
Publicado: (2011)

The Mouse Resistance Protein Irgm1 (LRG-47): A Regulator or an Effector of Pathogen Defense?
por: Hunn, Julia P., et al.
Publicado: (2010)

Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape
por: Wibmer, Constantinos Kurt, et al.
Publicado: (2017)

Neuropeptide Receptors: Novel Targets for HIV/AIDS Therapeutics
por: Branch, Donald R.
Publicado: (2011)

HIV Vaccine Development in the Aftermath of the STEP Study: Re-Focus on Occult HIV Infection?
por: Überla, Klaus
Publicado: (2008)

Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants
por: Klein, Florian, et al.
Publicado: (2014)

Although it's painful: The importance of stringent antibody validation
por: Meliopoulos, Victoria A., et al.
Publicado: (2018)

Synergy or Independence? Deciphering the Interaction of HLA Class I and NK Cell KIR Alleles in Early HIV-1 Disease Progression
por: Barbour, Jason D, et al.
Publicado: (2007)

Assessment of the application for renewal of authorisation of Lantharenol(®) (lanthanum carbonate octahydrate) for cats
por: Bampidis, Vasileios, et al.
Publicado: (2019)

Assessment of animal diseases caused by bacteria resistant to antimicrobials: Dogs and cats
por: Nielsen, Søren Saxmose, et al.
Publicado: (2021)

Phage “delay” towards enhancing bacterial escape from biofilms: a more comprehensive way of viewing resistance to bacteriophages
por: Abedon, Stephen T.
Publicado: (2017)

What use is the human genome for understanding the mouse?
por: Denny, Paul, et al.
Publicado: (2001)

Rise of the human-mouse chimeric brain models
por: Jiang, Peng, et al.
Publicado: (2022)

Safety and efficacy of cis‐norbixin di‐potassium salt (annatto F) for cats and dogs
por: Rychen, Guido, et al.
Publicado: (2017)

Discussions on the quality of antibodies are no reason to ban animal immunization
por: Custers, René, et al.
Publicado: (2020)

Advances in preclinical evaluation of experimental antibody-drug conjugates
por: Lyons, Scott K., et al.
Publicado: (2021)

The contrasting cultures of HIV and tuberculosis care
por: Daftary, Amrita, et al.
Publicado: (2015)

HIV control: Is getting there the same as staying there?
por: Goulder, Philip, et al.
Publicado: (2018)

Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody
por: Meijers, Matthijs, et al.
Publicado: (2021)

Evaluation of the application for new alternative biodiesel production process for rendered fat including Category 1 animal by‐products (BDI‐RepCat(®) process, AT)
por: Koutsoumanis, Konstantinos, et al.
Publicado: (2021)

The mouse genome sequence - the end of the tail, or just the beginning?
por: Rossant, Janet, et al.
Publicado: (2003)

Safety and efficacy of Lactobacillus reuteri NBF‐2 (DSM 32264) as a feed additive for cats
por: Bampidis, Vasileios, et al.
Publicado: (2019)

Antibody Responses to Mycoplasma pneumoniae: Role in Pathogenesis and Diagnosis of Encephalitis?
por: Meyer Sauteur, Patrick M., et al.
Publicado: (2014)

Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
por: Scheepers, Cathrine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vmo16iganj2bckc291rnh0flf2